0001181431-11-059292.txt : 20111207 0001181431-11-059292.hdr.sgml : 20111207 20111207163248 ACCESSION NUMBER: 0001181431-11-059292 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20111205 FILED AS OF DATE: 20111207 DATE AS OF CHANGE: 20111207 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Furiex Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001484478 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 271197863 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3900 PARAMOUNT PARKWAY STREET 2: SUITE 150 CITY: MORRISVILLE STATE: NC ZIP: 27560 BUSINESS PHONE: 919-456-7800 MAIL ADDRESS: STREET 1: 3900 PARAMOUNT PARKWAY STREET 2: SUITE 150 CITY: MORRISVILLE STATE: NC ZIP: 27560 FORMER COMPANY: FORMER CONFORMED NAME: PPD Therapeutics, Inc. DATE OF NAME CHANGE: 20100218 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: COVINGTON PAUL S CENTRAL INDEX KEY: 0001181153 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34641 FILM NUMBER: 111248870 MAIL ADDRESS: STREET 1: 3116 BRAEMAR DRIVE CITY: WILMINGTON STATE: NC ZIP: 28401 4 1 rrd327350.xml FORM 4 X0304 4 2011-12-05 0 0001484478 Furiex Pharmaceuticals, Inc. FURX 0001181153 COVINGTON PAUL S C/O FURIEX PHARMACEUTICALS, INC. 3900 PARAMOUNT PARKWAY, SUITE 150 MORRISVILLE NC 27560 0 1 0 0 Senior VP-Clinical Operations Common Stock 2011-12-05 4 P 0 2850 17.68 A 2923 D Stock Options (to buy) 9.11 2020-06-17 Common Stock 75691 75691 D Stock Options (to buy) 15.00 2021-05-09 Common Stock 26000 26000 D Stock Options (to buy) 13.16 2021-10-03 Common Stock 37944 37944 D This transaction was executed in multiple trades at prices ranging from $17.75 to $17.98. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. The options were awarded on 6/17/2010 and vest over three years, with one-third vesting on each of the first, second and third anniversaries of the date of grant, provided the Optionee's employment continues. The options were awarded on 5/9/2011. One-third of the options vest on the date of grant and the remaining two-thirds vest in two equal annual installments on the first and second anniversaries of the date of grant, provided the Optionee's employment continues. The options were awarded on 10/3/2011 and vest over three years, with one-third vesting on each of the first, second and third anniversaries of the date of grant, provided the Optionee's employment continues. /s/ Paul S. Covington 2011-12-07